Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
STADA Arzneimittel AG shares dropped the most in a year after the German generic-drug maker's planned 5.3 billion-euro (S$8.3 billion) sale to two buyout firms fell apart as a small group of investors held out for a better deal.
Only 65.5 per cent of the shares were tendered...